Clinical therapies have traditionally been developed using two-dimensional (2D) cell culture systems, which fail to accurately capture tissue complexity. Therefore, three-dimensional (3D) cell cultures are more attractive platforms to integrate multiple cues that arise from the extracellular matrix and cells, closer to an in vivo scenario. Here we report the development of a 3D cellular model for the in vitro assessment of the outcome of oxygen- and drug-dependent therapies, exemplified by photodynamic therapy (PDT). Using a synthetic self-assembling peptide as a cellular scaffold (RAD16-I), we were able to recreate the in vivo limitation of oxygen and drug diffusion and its biological effect, which is the development of cellular resistance to therapy. For the first time, the production and decay of the cytotoxic species singlet oxygen could be observed in a 3D cell culture. Results revealed that the intrinsic mechanism of action is maintained in both systems and, hence, the dynamic mass transfer effects accounted for the major differences in efficacy between the 2D and 3D models. We propose that this methodological approach will help to improve the efficacy of future oxygen- and drug-dependent therapies such as PDT.
Get full access to this article
View all access options for this article.
References
1.
YamadaK.M., CukiermanE.Modeling tissue morphogenesis and cancer in 3D. Cell, 130:601. 2007.
2.
GriffithL.G., SwartzM.A.Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol, 7:211. 2006.
DerdaR., LaromaineA., MammotoA., TangS.K.Y., MammotoT., IngberD.E., WhitesidesG.M.Paper-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A, 106:18457. 2009.
5.
PampaloniF., ReynaudE.G., StelzerE.H.The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol, 8:839. 2007.
6.
ShawK.R., WrobelC.N., BruggeJ.S.Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J Mammary Gland Biol Neoplasia, 9:297. 2004.
7.
CelliJ.P., RizviI., EvansC.L., Abu-YousifA.O., HasanT.Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J Biomed Opt, 15:051603. 2010.
8.
RizviI., CelliJ.P., EvansC.L., Abu-YousifA.O., MuzikanskyA., PogueB.W., FinkelsteinD., HasanT.Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res, 70:9319. 2010.
9.
KleinO.J., BhayanaB., ParkY.J., EvansC.L.In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform. Mol Pharm, 9:3171. 2012.
10.
AlbrechtD.R., UnderhillG.H., WassermannT.B., SahR.L., BhatiaS.N.Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods, 3:369. 2006.
11.
MehtaG., HsiaoA.Y., IngramM., LukerG.D., TakayamaS.Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release, 164:192. 2012.
LutolfM.P., HubbellJ.A.Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol, 23:47. 2005.
14.
ZhangS., HolmesT., LockshinC., RichA.Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci U S A, 90:3334. 1993.
HolmesT.C., de LacalleS., SuX., LiuG., RichA., ZhangS.Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. Proc Natl Acad Sci U S A, 97:6728. 2000.
17.
KisidayJ., JinM., KurzB., HungH., SeminoC., ZhangS., GrodzinskyA.J.Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proc Natl Acad Sci U S A, 99:9996. 2002.
18.
GarretaE., GenovéE., BorrósS., SeminoC.E.Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold. Tissue Eng, 12:2215. 2006.
WeishauptK.R., GomerC.J., DoughertyT.J.Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of the murine tumor. Cancer Res, 36:2326. 1976.
28.
RedmondR.W., KochevarI.E.Spatially resolved cellular responses to singlet oxygen. Photochem Photobiol, 82:1178. 2006.
29.
OchsnerM.Photophysical and photobiological processes in the photodynamic therapy of tumors. J Photochem Photobiol B., 39:1. 1997.
30.
Jimenez-BanzoA., SagristaM.L., MoraM., NonellS.Kinetics of singlet oxygen photosensitization in human skin fibroblasts. Free Radic Biol Med, 44:1926. 2008.
31.
HackbarthS., SchlothauerJ., PreussA., RoederB.New insights to primary photodynamic effects - Singlet oxygen kinetics in living cells. J Photochem Photobiol B, 98:173. 2010.
32.
SkovsenE., SnyderJ.W., LambertJ.D.C., OgilbyP.R.Lifetime and diffusion of singlet oxygen in a cell. J Phys Chem B, 109:8570. 2005.
33.
KanofskyJ.R.Measurement of singlet-oxygen in vivo: progress and pitfalls. Photochem Photobiol, 87:14. 2011.
34.
MaischT., SpannbergerF., RegensburgerJ., FelgentragerA., BaumlerW.Fast and effective: intense pulse light photodynamic inactivation of bacteria. J Ind Microbiol Biotechnol, 39:1013. 2012.
35.
SnyderJ.W., LambertJ.D.C., OgilbyP.R.5,10,15,20-tetrakis(N-methyl-4-pyridyl)-21H,23H-porphine (TMPyP) as a sensitizer for singlet oxygen imaging in cells: characterizing the irradiation-dependent behavior of TMPyP in a single cell. Photochem Photobiol, 82:177. 2006.
36.
PatitoI.A., RothmannC., MalikZ.Nuclear transport of photosensitizers during photosensitization and oxidative stress. Biol Cell, 93:285. 2001.
37.
MartiH.H., RisauW.Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A, 95:15809. 1998.
38.
ChirvonyV.S.Primary photoprocesses in cationic 5,10,15,20-meso-tetrakis(4-N-methylpyridiniumyl) porphyrin and its transition metal complexes bound with nucleic acids. J Porphyrins Phthalocyanines, 7:766. 2003.
39.
PaoliV.M.D., PaoliS.H.D., BorissevitchL.E., TedescoA.C.Fluorescence lifetime and quantum yield of TMPyPH2 associated with micelles and DNA. J All Comp., 344:27. 2002.
40.
SnyderJ.W., SkovsenE., LambertJ.D.C., PoulsenL., OgilbyP.R.Optical detection of singlet oxygen from single cells. Phys Chem Chem Phys, 8:4280. 2006.
41.
SchweitzerC., SchmidtR.Physical mechanisms of generation and deactivation of singlet oxygen. Chem Rev, 103:1685. 2003.
42.
WilkinsonF., HelmanW.P., RossA.B.Rate constants for the decay and reactions of the lowest electronically excited singlet state of molecular oxygen in solution. An expanded and revised compilation. J Phys Chem Ref Data, 24:663. 1995.
43.
SnyderJ.W., SkovsenE., LambertJ.D.C., OgilbyP.R.Subcellular, time- resolved studies of singlet oxygen in single cells. J Am Chem Soc, 127:14558. 2005.
44.
ChiuL.L., SunC.H., YehA.T., TorkianB., KaramzadehA., TrombergB., WongB.J.Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med, 37:231. 2005.
45.
ByunJ.Y., LeeG.Y., ChoiH.Y., MyungK.B., ChoiY.W.The expressions of TGF-beta(1) and IL-10 in cultured fibroblasts after ALA-IPL photodynamic treatment. Ann Dermatol, 23:19. 2011.
46.
MendozaJ., SebastianA., AllanE., AllanD., MandalP., Alonso-RasgadoT., BayatA.Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion. Arch Dermatol Res, 304:549. 2012.
47.
BhowmickN.A., NeilsonE.G., MosesH.L.Stromal fibroblasts in cancer initiation and progression. Nature, 432:332. 2004.
48.
BigelowC.E., MitraS., KnuechelR., FosterT.H.ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids. Br J Cancer, 85:727. 2001.
49.
HuygensA., HuygheD., BormansG., VerbruggenA., KamuhabwaA.R., RoskamsT., de WitteP.A.M.Accumulation and photocytotoxicity of hypericin and analogs in two- and three-dimensional cultures of transitional cell carcinoma cells. Photochem Photobiol, 78:607. 2003.
50.
MadsenS.J., SunC.H., TrombergB.J., CristiniV., De MagalhaesN., HirschbergH.Multicell tumor spheroids in photodynamic therapy. Lasers Surg Med, 38:555. 2006.
51.
WrightK.E., LinikerE., LoizidouM., MooreC., MacrobertA.J., PhillipsJ.B.Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model. Br J Cancer, 101:658. 2009.
52.
EvansC.L., Abu-YousifA.O., ParkY.J., KleinO.J., CelliJ.P., RizviI., ZhengX., HasanT.Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One, 6:e23434. 2011.
53.
RubioN., FleuryS.P., RedmondR.W.Spatial and temporal dynamics of in vitro photodynamic cell killing: extracellular hydrogen peroxide mediates neighbouring cell death. Photochem Photobiol Sci, 8:457. 2009.
54.
FeineI., PinkasI., SalomonY., ScherzA.Local oxidative stress expansion through endothelial cells—a key role for gap junction intercellular communication. PLoS One, 7:e41633. 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
